Found 2 hits in this display Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Mitotic checkpoint serine/threonine-protein kinase BUB1
(Homo sapiens (Human)) | BDBM379090
(Preparation of formic acid-3-chloro-4-({3-[5-metho...)Show SMILES CNC(=O)c1ccc(Cn2nc(-c3ncc(OC)c(Nc4ccncc4)n3)c3ccccc23)c(Cl)c1 Show InChI InChI=1S/C26H22ClN7O2/c1-28-26(35)16-7-8-17(20(27)13-16)15-34-21-6-4-3-5-19(21)23(33-34)25-30-14-22(36-2)24(32-25)31-18-9-11-29-12-10-18/h3-14H,15H2,1-2H3,(H,28,35)(H,29,30,31,32) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 8.90 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson & Johnson Pharmaceutical
| Assay Description Bub1-inhibitory activities of compounds described in the present invention were quantified using a time-resolved fluorescence energy transfer (TR-FRE... |
J Med Chem 51: 4150-69 (2008)
BindingDB Entry DOI: 10.7270/Q2RV0R1M |
More data for this Ligand-Target Pair | |
Mitotic checkpoint serine/threonine-protein kinase BUB1
(Homo sapiens (Human)) | BDBM379090
(Preparation of formic acid-3-chloro-4-({3-[5-metho...)Show SMILES CNC(=O)c1ccc(Cn2nc(-c3ncc(OC)c(Nc4ccncc4)n3)c3ccccc23)c(Cl)c1 Show InChI InChI=1S/C26H22ClN7O2/c1-28-26(35)16-7-8-17(20(27)13-16)15-34-21-6-4-3-5-19(21)23(33-34)25-30-14-22(36-2)24(32-25)31-18-9-11-29-12-10-18/h3-14H,15H2,1-2H3,(H,28,35)(H,29,30,31,32) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 11 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson & Johnson Pharmaceutical
| Assay Description Bub1-inhibitory activities of compounds described in the present invention were quantified using a time-resolved fluorescence energy transfer (TR-FRE... |
J Med Chem 51: 4150-69 (2008)
BindingDB Entry DOI: 10.7270/Q2RV0R1M |
More data for this Ligand-Target Pair | |